Comments
Loading...
Vaxart (NASDAQ:VXRT) Stock Quotes, Forecast and News Summary
Vaxart Stock (NASDAQ: VXRT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Vaxart (VXRT) stock?
You can purchase shares of Vaxart (NASDAQ:VXRT) through any online brokerage.
Who are Vaxart (VXRT) competitors?
Other companies in Vaxart’s space includes: Macrogenics (NASDAQ:MGNX), Molecular Partners (NASDAQ:MOLN), 4D Molecular Therapeutics (NASDAQ:FDMT), Zentalis Pharma (NASDAQ:ZNTL) and Monopar Therapeutics (NASDAQ:MNPR).
What is the forecast, or price target, for Vaxart (VXRT) stock?
Vaxart has a consensus price target of $3.33.
What is the current price for Vaxart (VXRT)?
The stock price for Vaxart (NASDAQ: VXRT) is $0.7956 last updated January 22, 2025 at 1:54 PM EST.
Does Vaxart (VXRT) pay a dividend?
There are no upcoming dividends for Vaxart.
When is Vaxart (NASDAQ:VXRT) reporting earnings?
Vaxart’s Q4 earnings are confirmed for Thursday, March 13, 2025.
Is Vaxart (VXRT) going to split?
There is no upcoming split for Vaxart.
What sector and industry does Vaxart (VXRT) operate in?
Vaxart is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.